✦ LIBER ✦

Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors

✍ Scribed by Elaine T. Lam; Sanjay Goel; Larry J. Schaaf; Gillian F. Cropp; Alison L. Hannah; Yiqing Zhou; Barbara McCracken; Brandi I. Haley; Robert G. Johnson; Sridhar Mani; Miguel A. Villalona-Calero

Publisher: Springer
Year: 2011
Tongue: English
Weight: 280 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1724-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib in combination with docetaxel

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

✍ Francisco Robert; Alan Sandler; Joan H. Schiller; Glenn Liu; Karen Harper; Lev V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Phase I dose escalation study of weekly

Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy

✍ Ahmad Awada; Martine J. Piccart; Suzanne F. Jones; Ronald A. Peck; Thierry Gil; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 358 KB

Phase I dose escalation study of MK-0457

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

A dose escalation study of weekly doceta

A dose escalation study of weekly docetaxel in patients with advanced solid tumors

✍ Ch. Kouroussis; S. Agelaki; D. Mavroudis; J. Souglakos; S. Kakolyris; K. Kalbaki 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 82 KB

Phase I dose-escalation study of tezacit

Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors

✍ Johanna C. Bendell; Joseph P. Eder; Jeffrey W. Clark; Panagiotis Fidias; Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

Tesetaxel, a new oral taxane, in combina

Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors

✍ Muhammad Wasif Saif; John Sarantopoulos; Amita Patnaik; Anthony W. Tolcher; Chri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB